A randomised trial to assess the effect of Sea-alpa for the patients with mild cognitive impairment (MCI).
Not Applicable
Recruiting
- Conditions
- mild cognitive impairment
- Registration Number
- JPRN-UMIN000002345
- Lead Sponsor
- Department of Neuropsychiatry, Institute of Clinical Medicine University of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Meeting DSM-IV TR criteria for dementing illnesses. 2) Having serious or unstable illnesses. 3) Having a history within past 5 years of serious infections disease affecting the brain and/or malignant diseases. 4) Having a history of alcohol or drug abuse or dependence (on DSM-IVTR) within the past 5 years. 5) Receiving any types of anti-Alzheimer drugs. 6) Recent (within 4 weeks) initiation of medications that affect the central nervous system.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score in Japanese version of ADAS-Cog and Mini Mental State Examination.
- Secondary Outcome Measures
Name Time Method Scores in Japanese version of ADCS-ADL, Geriatric Depression Scale.